Mechanism of Euodiae Fructus stir-fried with water decoction of Coptidis Rhizoma in treatment of chronic colitis based on UPLC-Q-TOF-MS, network pharmacology and experimental verification.
10.19540/j.cnki.cjcmm.20220314.402
- Author:
Wen-Yan ZHAO
1
;
Qian XIANG
1
;
Chan WANG
1
;
Xiao-Ying WU
1
;
Ying-Hui ZHU
1
;
Dan-Yang YANG
1
;
Yu-Xun CHEN
1
;
Xiao-Lin XIAO
1
;
Qian-Feng GONG
1
;
Huan YU
1
Author Information
1. School of Pharmacy, Jiangxi University of Chinese Medicine Nanchang 330004, China.
- Publication Type:Journal Article
- Keywords:
Euodiae Fructus stir-fried with water decoction of Coptidis Rhizoma;
PI3K-Akt pathway;
UPLC-Q-TOF-MS;
chronic colitis;
network pharmacology
- MeSH:
Animals;
Mice;
Water;
Drugs, Chinese Herbal/pharmacology*;
Network Pharmacology;
Proto-Oncogene Proteins c-akt;
Colitis/drug therapy*;
Chronic Disease;
Molecular Docking Simulation
- From:
China Journal of Chinese Materia Medica
2022;47(19):5316-5326
- CountryChina
- Language:Chinese
-
Abstract:
To elucidate the mechanism of Euodiae Fructus stir-fried with water decoction of Coptidis Rhizoma in the treatment of chronic colitis, this study employed ultra performance liquid chromatography-quadrupole time-of-flight mass spectrometry(UPLC-Q-TOF-MS), network pharmacology, and experimental verification to predict the involved targets and signaling pathways. The chronic colitis mouse model was constructed to verify the core targets. A total of 48 compounds in the herbal medicine were identified by UPLC-Q-TOF-MS. SwissTargetPrediction was used to screen the potential active components and drug targets. GeneCards, OMIM, PharmGKB, and TDD were used to search for the disease targets. A total of 31 active ingredients, 453 targets of the herbal medicine, and 3 960 targets of chronic colitis were obtained. The common targets shared by the herbal medicine and chronic colitis were introduced into STRING to construct the protein-protein interaction(PPI) network, and CytoNCA plug-in was used to screen the key targets. A total of 90 key targets were obtained, and the key active components included isorhamnetin, quercetin, limonin, and oxyberberine. GO annotation and KEGG pathway enrichment for the key targets were carried out via DAVID. The targets were mainly involved in the positive regulation of protein phosphorylation, positive regulation of nitric oxide biosynthetic process, and negative regulation of apoptotic process. The medicine may treat chronic colitis through PI3 K-Akt, VEGF, HIF-1, and TNF signaling pathways. A mouse model of chronic colitis was established and then treated with Euodiae Fructus stir-fried with the water decoction of Coptidis Rhizoma. The experimental results demonstrated that the medicine can alleviate the pathological damage of colon, significantly reduce the levels of IL-1β, IL-6, and TNF-α, inhibit the activation of PI3 K/Akt pathway, and down-regulate the expression of VEGFA in the treatment of chronic colitis.
